Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

19.64 +0.13 (+0.67%)
As of 10:34:40 AM EDT. Market Open.
Trade SHC on Coinbase
Chart Range Bar
Loading chart for SHC
  • Previous Close 19.51
  • Open 19.51
  • Bid 19.61 x 100
  • Ask 23.67 x 200
  • Day's Range 19.51 - 19.73
  • 52 Week Range 13.09 - 19.85
  • Volume 245,307
  • Avg. Volume 2,864,933
  • Market Cap (intraday) 5.605B
  • Beta (5Y Monthly) 1.77
  • PE Ratio (TTM) 34.46
  • EPS (TTM) 0.57
  • Earnings Date (est.) Nov 3, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22.72

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

soterahealth.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 8/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SHC
11.34%
S&P 500 (^GSPC)
12.07%

1-Year Return

SHC
19.76%
S&P 500 (^GSPC)
18.65%

3-Year Return

SHC
22.22%
S&P 500 (^GSPC)
74.14%

5-Year Return

SHC
21.31%
S&P 500 (^GSPC)
71.63%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 321.38M
Earnings 53.64M
Profit Margin 16.69%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
10.0%
12.0%
14.0%
16.0%

Analyst Insights

View More

Analyst Price Targets

18.00 Low
22.72 Average
19.64 Current
25.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/7/2026
Analyst Citigroup
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 23 -> 25

Statistics

View More

Valuation Measures

Annual
As of 8/24/2026
  • Market Cap

    5.57B

  • Enterprise Value

    7.48B

  • Trailing P/E

    33.63

  • Forward P/E

    19.38

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.55

  • Price/Book (mrq)

    8.22

  • Enterprise Value/Revenue

    6.07

  • Enterprise Value/EBITDA

    13.86

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.44%

  • Return on Assets (ttm)

    8.60%

  • Return on Equity (ttm)

    27.78%

  • Revenue (ttm)

    1.22B

  • Net Income Avi to Common (ttm)

    163.48M

  • Diluted EPS (ttm)

    0.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    356.95M

  • Total Debt/Equity (mrq)

    340.73%

  • Levered Free Cash Flow (ttm)

    153.97M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

19.64 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 08/20/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Lowering target price to $19.00

    SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $19.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $20.00

    SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $20.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
  • What does Argus have to say about SHC?

    SOTERA HEALTH CO has an Investment Rating of HOLD; a target price of $19.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: